Scientific Program · PDDS 2024

PDDS 2024 — Scientific Program

Day-by-day session and presentation schedule

The full PDDS 2024 scientific program across 3 days — keynotes, oral presentations, and posters. Talks are ordered by program prominence within each day.

Day 1

Day 1

  1. Oral · In-Person

    Personalized and Precision Medicine (PPM) as a unique healthcare model to be set up via biodesign, bio- and chemical engineering, translational applications, and upgraded business modeling to secure the human healthcare and biosafety

    Sergey Suchkov · N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation

    Traditionally a disease has been defined by its clinical presentation and observable characteristics, not by the underlying molecular mechanisms, pathways and systems biology-related processes specific to a particular…

  2. Oral · In-Person

    Pharmacokinetic properties of TNX-102 SL, a sublingual formulation of cyclobenzaprine hydrochloride

    Bruce Daugherty · Tonix Pharmaceuticals, United States

    TNX-102 SL is a sublingual formulation for cyclobenzaprine (CBP) hydrochloride (HCl) designed for bedtime dosing that is being developed for fibromyalgia (FM) via improvement in sleep quality. TNX-102 SL is a eutectic…

  3. Oral · In-Person

    Mannitol as eutectic forming agent for improved sublingual delivery of Cyclobenzaprine HCl

    Marino Nebuloni · University of Insubria, Italy

    In solid drug product formulation, the knowledge of possible interactions between the drug substance and the excipients is a crucial point for the prediction of chemical and physical stability. Often, an excipient(s)…

  4. Oral

    Clinical decision making in advanced and metastatic breast cancer cases between PARP inhibitors and CDK4/6 inhibitors

    Priya Hays · Hays Documentation Specialists, LLC, United States

    Background: PARP inhibitors and CDK 4/6 inhibitors have been studied extensively as model targeted agents for advanced and metastatic breast cancer with hormone receptor positive/HER2 negative molecular subtype, the…

  5. Oral

    Gastrointestinal performance simulation system for the analysis of eltrombopag formulations

    Stella Kafkala · Genepharm Pharmaceutical Company, Greece

    Eltrombopag olamine is the active substance of the innovator product Revolade, which is indicated for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (ITP) and acquired severe aplastic anemia…

  6. Oral

    Microemulsion based in situ gel of Erythromycin for Ocular Ailments

    Dasharath Muljibhai Patel · Gujarat Technological University, India

    Background: Conventional preparation of erythromycin ointment is available in the market as an ocular formulation. Ointment dosage form is linked to many side effects, including transient blurred vision, irritation and…

  7. Oral

    Preparation and characterization of inhaled luteolin nano-liposomes for the potential management of pulmonary arterial hypertension

    Fatma Haddad · University of Bradford, United Kingdom

    Luteolin is a natural flavonoid abundant in several fruits, vegetables, and medicinal herbs. Although luteolin has numerous pharmacological activities, its low water solubility and bioavailability restrict its…

  8. Oral

    Supercritical microfluidic system for production of nanoparticles and liposomes for pharmaceutical formulation

    Yusuke Shimoyama · Tokyo Institute of Technology, Japan

    Pharmaceutical formulation techniques have been developed as achieving controlled-release system and high bioavailability of active pharmaceutical ingredients (APIs). Formation of the pharmaceutical suspension with…

  9. Oral

    The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale

    Sergey Suchkov · N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation

    A new systems approach to subclinical, predictive and/or diseased states and wellness resulted in a new Hi Tech trend in the healthcare services, namely, personalized and precision medicine (PPM). Meanwhile, despite…

  10. Oral

    Development and evaluation of prolonged-release dutasteride transdermal delivery system

    Shereen M Assaf · Jordan University of Science and Technology, Jordan

    Benign prostatic hyperplasia (BPH), an enlargement of the prostate affecting older men, leads to urinary complications. Oral administration of Dutasteride (DTS) is a common treatment, but it poses challenges for the…

  11. Oral

    Potential bruton tyrosine kinase (BTK) inhibitors determined by virtual screening, molecular docking, and molecular dynamics simulation studies

    Alper Onder · Canakkale Onsekiz Mart University, Turkey

    Bruton tyrosine kinase (BTK) is a downstream mediator of the B cell receptor (BCR) signalling pathway and affects B cell proliferation and differentiation. Evidence showing BTK expression in the majority of…

  12. Oral

    In silico, synthesis, and in vitro studies of novel FOXM1 Inhibitors for targeted triple negative breast cancer therapy

    Ferah Comert Onder · Canakkale Onsekiz Mart University, Turkey

    Triple-negative breast cancer (TNBC) is subtype of breast cancer is known for aggressive, leading to early relapses, metastasis and poor clinical prognosis. Significant heterogeneity and drug resistant phenotype and…

  13. Oral

    Design and assessment of transdermal delivery system containing Levodopa-Loaded Nanoparticles

    Shereen M Assaf · Jordan University of Science and Technology, Jordan

    Levodopa, an essential precursor of dopamine, was widely used to address motor disorders in the early stages of Parkinson's disease. However, its effectiveness was hindered by a short plasma half-life, enzymatic…

Day 2

Day 2

  1. Keynote · Virtual

    The importance of invitro discriminatory tests in the development of a sublingual dosage form of TNX102 SL(Cyclobenzaprine HCl) tablets

    Siobhan Fogarty · Tonix Pharma Limited, Ireland

    The formulation of cyclobenzaprine HCl contained in TNX-102 SL has been designed specifically for sublingual administration. Earlier clinical studies indicated that the addition of a basifying agent was necessary for…

  2. Keynote · Virtual

    Pharmaceutical continuous manufacturing: The interaction between different units and tablet properties

    Riyadh Al Asady · University of Sheffield, United Kingdom

    In a multi-processes pharmaceutical continuous tablet production line such as ConsiGmaTM -25, the quality of the final tablet is a function of different processes and formulation parameters of different units. The…

  3. Keynote · Virtual

    Lipid media with supercritical CO2 for promoted formation of itraconazole cocrystals

    Yuna Tatsumi · Tokyo Institute of Technology, Japan

    Pharmaceutical cocrystal is one of the crystal engineering techniques to improve the solubility and bioavailability of active pharmaceutical ingredients (APIs). Cocrystal is a crystal composed of API and other molecules…

  4. Keynote · Virtual

    Gastrointestinal performance simulation system for the analysis of eltrombopag formulations

    Savvopoulos Pantelis · Genepharm Pharmaceutical Company, Greece

    Eltrombopag olamine is the active substance of the innovator product Revolade, which is indicated for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (ITP) and acquired severe aplastic anemia…

  5. Keynote · Virtual

    An updated review on the central mechanism of action of paracetamol: Experimental evidence and potential clinical impact

    Rassa Pegahi · UPSA, France

    Paracetamol remains the recommended first-line option for mild-to-moderate acute pain in general population and particularly in vulnerable populations. Despite its wide use, debate exists regarding the analgesic…

  6. Keynote · Virtual

    Paeoniflorin effectively inhibit melanoma growth through induce senescence and ER stress converging on the Calpain1/ERK5/P21 axis

    Shu Chun Liu · Show Chwan Memorial Hospital, Taiwan

    Background: Senescence leads to permanent cell-cycle arrest and is a potential target for cancer therapy. Paeoniflorin (PAE) is a monoterpene isolated from Traditional Chinese Medicine (TCM) Paeonia Alba, which has been…

  7. Keynote · Virtual

    Polymeric-based formulation for intelligent drug delivery

    Mutaz S Salem · Jordan University of Science and Technology, Jordan

    Conventional oral formulations are mainly absorbed in the small intestine. This limits their use in the treatment of some diseases associated with the colon, where the drug has to act topically at the inflammation site.…

  8. Oral · In-Person

    Emerging formulation and delivery applications of vitamin E TPGS

    Andreas M Papas · Antares Health Products, United States

    Vitamin E TPGS (d-α-tocopheryl polyethylene glycol 1000 succinate) combines the functions of solubilizer, emulsifier, and absorption enhancer of lipophilic and poorly soluble drugs. In addition, it enhances drug…

  9. Oral · In-Person

    Drug design for the development of long-acting injectables

    Thomas Ullrich · Novartis Biomedical Research, Switzerland

    Long-acting injectable (LAI) medications represent the combination of a powerful drug substance and an injectable drug formulation that guarantees that the affected tissue is consistently exposed to the active molecule…

  10. Oral · In-Person

    Clinical pharmacology of aprocitentan (an endothelin receptor antagonist) – The most recent quality progress in treatment of resistant hypertension

    Miroslav Radenkovic · University of Belgrade, Serbia

    Hypertension is a common condition characterized by persistently high blood pressure (140/90 mmHg or higher). Lowering high blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes…

  11. Oral · In-Person

    Crystallographic in pharmaceutical filed: new frontiers

    Maria Cristina Gamberini · University of Modena and Reggio Emilia, Italy

    Most commonly produced and marketed drugs are formulated with the pharmacologically active ingredient in solid form (crystalline or amorphous). The solid form is carefully chosen for its characteristics, to increase the…

  12. Oral

    An updated review on the central mechanism of action of paracetamol (Acetaminophen): Experimental evidence and potential clinical impact

    Rassa Pegahi · UPSA, France

    Paracetamol remains the recommended first-line option for mild-to-moderate acute pain in general population and particularly in vulnerable populations. Despite its wide use, debate exists regarding the analgesic…

  13. Oral

    Innovations in DNA and RNA vaccine technology their impact on treatment efficacy and delivery

    Fatemeh Ahmadvand · University of the Genova, Italy

    Advances in genetic engineering vaccines have made DNA vaccines a highly promising option for hereditary and acquired illnesses. The main obstacle; nevertheless, is the absence of an ideal delivery system, which…

  14. Oral

    Hybrid compounds: A useful strategy to overcome limited pharmaceutical profile

    Barbara De Filippis · University of Chieti, Italy

    Hybrid compounds are artificial scaffolds made of two or more pharmacophores that are jointed or overlapped in a single chemical entity. The strategy of combining two different and independently acting compounds into…

  15. Oral

    An enteric capsule for oral drug delivery made from natural materials

    Anders B Christensen · Apillet, Denmark

    Apillet has developed a unique Oral drug delivery concept (APIVault) which enable targeted release in the intestine of Sensitive (bio)pharmaceuticals, Probiotics and Nutraceuticals. Such compounds are prone to…

  16. Oral

    Development of a sensitive method for the determination of enrofloxacin in falsified veterinary products

    Ibrahim A Al Othaim · Saudi Food & Drug Authority, Saudi Arabia

    Background: Enrofloxacin (enro) is a broad-spectrum fluoroquinolone antibiotic active against both Gram-positive and Gram-negative bacteria. It is used extensively in both animals and humans due to its high…

Day 3

Day 3

  1. Keynote

    Why we need to advance from data focus to knowledge focus for managing healthcare transformation?

    Bernd Blobel · University of Regensburg, Germany

    Health and social care systems around the globe currently undergo a transformation towards personalized, preventive, predictive, participative precision medicine (5PM), considering the individual health status…

  2. Keynote

    Unveiling the binding interactions of selected antimalarial drugs with major plasma transporter

    Saad Tayyab · UCSI University, Malaysia

    Using a variety of spectroscopic methods and in silico analysis, the binding interactions between three antimalarial medications, mefloquine (MEF), lumefantrine (LUM), and pyrimethamine (PYR) and the primary plasma…

  3. Keynote

    Photodegradation of two pharmaceutical namely levofloxacin and atorvastatin via Chitosan/Ag/TiO2 3D printed scaffold

    Delia Teresa Sponza · Dokuz Eylul University, Turkey

    Pharmaceuticals are highly persistent towards hydrolysis, adsorption, biodegradation, and abiotic degradation .As a result, such pharmaceutical compounds are not effectively removed during sewage treatment. Furthermore…

  4. Keynote

    Liver biopsy handling of metabolic-associated fatty liver disease (MAFLD): The children's hospital of eastern ontario grossing protocol

    Consolato M Sergi · University of Alberta, Canada

    Introduction: Metabolic-(non-alcoholic) associated fatty liver disease (MAFLD/NAFLD) has increasingly become a worldwide epidemic. It has been suggested that renaming NAFLD to MAFLD is critical in identifying patients…

  5. Keynote

    Perillyl alcohol (NEO100), a monoterpene with versatile applications for cancer therapy

    Axel H Schonthal · University of Southern California, United States

    Perillyl alcohol is a naturally occurring monoterpene related to limonene. We have synthesized a clinical-grade version, called NEO100 (NeOnc Technologies, Inc., Los Angeles, California), which has revealed a variety of…

  6. Keynote

    Preparation and characterization of fibers crafted from PCL/PVP-ChAgG, coupled with investigating their suitability as wound dressings.

    Luis Jesus Villarreal Gomez · Universidad Autónoma de Baja California, Mexico

    Wound dressings play a pivotal role in wound care by cleansing, shielding, and covering wounds, thereby influencing healing duration, cost-effectiveness, and patient comfort. Electrospun fibers emerge as a promising…

  7. Keynote

    Hydrogen sulfide and substance P: Novel mediators and therapeutic targets for acute pancreatitis

    Madhav Bhatia · University of Otago, New Zealand

    Acute pancreatitis is a common clinical condition, for which there is no satisfactory treatment available at this time. Excessive systemic inflammatory response syndrome (SIRS) in acute pancreatitis leads to distant…

  8. Keynote

    Integrating QbD for the solubility amelioration of ivacaftor loaded solid lipid nanoparticles in-vitro & in-vivo

    Bhupendra Gopalbhai Prajapati · Parul University, India

    The present investigation is focused on the application of the Quality by Design (QbD) approach for the development and optimization of SLN formulation of Ivacaftor (IVF). IVF SLN was formulated with the help of…

  9. Keynote · In-Person

    Structural scheme of an electro magneto elastic actuator for nanomedical research

    Afonin S.M · National Research University of Electronic Technology, Russian Federation

    An electro magneto elastic actuator is electro magneto mechanical device intended for actuation of mechanisms, systems based on the piezoelectric, electrostriction, piezomagnetic, magnetostriction effects, converts…

  10. Poster

    Computational modelling for enhanced drug delivery in drug-coated balloon treatment

    Elisabetta Stretti · University of Patras, Greece

    Drug-coated balloon (DCB) treatment has recently emerged as an effective non-stent-based strategy for the treatment of atherosclerotic arteries in peripheral artery disease (PAD). DCBs are designed to dilate into the…

  11. Poster

    Impact of implementation of antimicrobial stewardship (AMSP) and infection prevention and measures (IPC) on MDRO profiles in a tertiary care hospital of India

    Raja Chakraverty · Indian Council of Medical Research, India

    The study was conducted to gather information to assess the extent of impact of antimicrobial stewardship (AMSP) practices on antimicrobial prescribing patterns and bacterial resistance profiles among indoor patients…

  12. Poster

    Unveiling green chemistry: Exploring sustainable practices

    Pratip kashinath chaskar · D Y Patil University School of Pharmacy Navi Mumbai, India

    The forthcoming presentation will delve into the fundamental tenets of Green Chemistry, highlighting key methodologies such as Phase Transfer Catalysis (PTC), Ionic Liquids (IL), Sonochemistry, and Microwave Irradiation…

  13. Poster

    Comparison of in vitro drug dissolution profiles: Current state and examination of etravirine tablets

    Ayse Nur Oktay · University of Health Sciences-Gulhane Faculty of Pharmacy, Turkey

    In vitro drug dissolution is a laboratory test of drug tablets to assess product quality. The test measures drug release (i.e. drug dissolution) from tablets. There are numerous scenarios during drug development, as…

  14. Poster

    Design and development of controlled release systems: Versatility in drug formulation

    Natassa Pippa · University of Athens, Greece

    Controlled-release drug delivery systems exhibit a gamut of benefits, including improved therapeutic efficacy, reduced side effects, improved patient compliance, and optimized medicine use. For this reason, there is…

  15. Poster

    Structure elucidation of drug targets through homology modeling in the AI era

    Muhammed Tilahun Muhammed · Suleyman Demirel University, Turkey

    Target/Structure-based drug design needs the presence of the target structure to move forward in the drug discovery process. However, the number of macromolecule structures available in the available data banks is…

  16. Poster

    Mesenchymal stromal cells as therapeutic tools in immune disorders: Promising evidence from in vitro results

    Panagiotis Mallis · Biomedical Research Foundation Academy of Athens, Greece

    Background: Mesenchymal Stromal Cells (MSCs), a multipotent stem cell population which can efficiently be obtained from different tissue sources, exert key specific regenerative and immunomodulatory properties. However…

  17. Poster

    Novel 2, 5-disubstituted oxadiazole scaffolds act as potential antitumour and antibacterial agents

    Asish Bhaumik · School of Pharmaceutical Science, India

    Introdution: 1, 3, 4-oxadiazole is a five membered heterocyclic aromatic compound containing two nitrogen atom at position three and four and one oxygen atom present at position one. 1, 3, 4 oxadiazole is thermally…

  18. Poster

    Role of natural polymers in drug delivery system

    Dharmendra Kumar · Swami Vivekanand Subharti University, India

    In recent years, various types of natural polymers have gained prominence in drug delivery systems due to their biocompatibility, biodegradability, and ease of modification. Recent research has further enhanced the…

  19. Poster

    Synthetic antimicrobial peptides as potent therapeutic agents

    Deepika Sharma · CGC Mohali Punjab, India

    Among the fungal genera, members of the genus Candida are most common causal organisms of human infections. In recent years, increasing drug resistance in fungal pathogenic strains specifically, clinical strains require…

  20. Poster

    UPLC method development and validation for the estimation of sulbactam and durlobactum in pharmaceutical dosage form

    Rayhan Shahid Shanavas · Oakridge International School, India

    Infectious diseases especially associated with multidrug resistant pathogens in critically ill patients is an area of global research and concern for healthcare professionals across both private and public sector.…

  21. Poster

    PCSK9 roles beyond cholesterol lowering

    Maria Borrell · Sant Pau Research Institute, Spain

    Atherosclerosis, the leading cause of cardiovascular diseases, is driven by high blood cholesterol levels and chronic inflammation. The disruption of the hepatic interaction between Proprotein Convertase…

  22. Poster

    Human papillomavirus vaccines and impact on decreasing of infection the population

    Merita Kucuku · Freelance consultant, Albania

    Human Papillomavirus (HPV) vaccines are vaccines used for vaccination against human papillomavirus infection. HPV vaccines prevent infection from different types of human papillomavirus which cause risk for cervical…

  23. Poster

    A novel method of active medication delivery via microneedles using a belousov-zhabotinsky oscillating hydrogel

    Shripriya Kalbhavi · Lynbrook High School, United States

    Despite the widespread use of hypodermic needles in intradermal medication delivery, they remain a source of pain and trauma in patients young and old. The research introduces a novel approach to active medication…

  24. Poster

    Health risks associated with exposure to organic sunscreens during pregnancy

    Anna W Sobanska · Medical University of Lodz, Poland

    Pregnant women are exposed to a variety of environmental pollutants – pesticides, drugs, substances of abuse or cosmetic raw materials that enter the body of a mother-to-be by a variety of routes - oral (with…

  25. Poster

    Breakthrough, fast, precise and inexpensive 3D bioprinting of organoids and blood vessels

    Vyacheslav R Shulunov · Institute of Physical Materials Science of the Siberian Branch of the Russian Academy of Science, Russian Federation

    The calculated specifications of Roll Porous Scaffold (RPS) are orders of magnitude superior to all currently dominant 3D bioprinters in speed, volume, and print density without the use of expensive equipment and…

  26. Poster

    AI-guided spectroscopy and recombinant DNA technologies to discover the new lantibiotics and phytobiotics against multi-drug-resistant infections

    Asit Kumar Chakraborty · Vidyasagar University, India

    MDR-bacteria causes sepsis and death in patients due to their power to inactivate antibiotics like ampicillin, cefotaxime, tetracycline, streptomycin, chloramphenicol, erythromycin and ciprofloxacin. The mdr genes (amp…

  27. Poster

    Telomere length, inflammatory markers and oxidative stress in pre-eclamptic women

    Preeti Sharma · Autonomous State Government Medical College, India

    Introduction: Preeclampsia(PE) is pregnancy related syndrome which is mainly by gestational hypertension with proteinuria. it affects 2 to 10 % of pregnant women. Improper maternal spiral artery remodelling leads to…

  28. Poster

    Novel chromogenic method as a sensitive technique in estimating analytes

    Khagga Bhavyasri · Osmania University, India

    To develop and validate a simple and sensitive UV spectrophotometric method for Quantification of Hesperidin in bulk and Ayurveda formulation including plant extracts using chromogenic compound Gibb’s reagent (2…

  29. Poster

    Preparation and evaluation of herbosome of herbal plant of Lawsonia inermis L. for topical application

    Rudra Pratap Singh Rajput · Royal College of Pharmacy, India

    Background: Lawsonia inermis L. (Lawsone) was reported to contain carbohydrates, proteins, flavonoids and phenolic compounds, alkaloids, terpenoids. The plant has also been reported to have hepatoprotective…

  30. Poster

    Targeted downregulation of VEGF-A to inhibit angiogenesis in psoriasis using CRISPR/Cas9 complexed lipopolymeric nanoplexes

    Abhay Tharmatt · BITS Pilani, India

    Psoriasis, an incurable chronic inflammatory skin disease, is characterised by enhanced angiogenesis, abnormal keratinocyte differentiation, and immune cell invasion. Angiogenesis, a critical factor in endothelial cell…

  31. Poster

    The impact of climate change on medicinal plant availability and efficacy

    Ali Yetgin · Institute of Nature and Applied Sciences, Department of Biotechnology, Adana, Turkey, Turkey

    Medicinal plants have been fundamental in both traditional and modern medicine, offering a wide array of bioactive compounds crucial for therapeutic purposes. The escalating impact of climate change presents notable…

  32. Poster

    Natural plant-based extract-mediated cell death induction potential in human cancer cells -in vitro and in silico strategies for drug development

    Suresh P.K · VIT University, India

    Extracts from plant sources have been mined for their anti-cancer potential. The n-butanolic extract of the leaves of A.muricata exhibited a higher cytotoxic potential in MDA-MB-435s & HaCaT cells in comparison with…

  33. Poster

    Pharmaceuticals in the Environment: Boon or Bane

    Neha Agarwal · Navyug Kanya Mahavidyalaya, India

    Pharmaceuticals are essential to ensure the high standards of human health and wellbeing. Extensive and uncontrolled usage under different classes such as antibiotics, analgesics, antipyretics, antidepressant…

  34. Poster

    Global drug development - Trends, challenges and opportunities

    Gurpreet Singh · IQVIA, United Kingdom

    The entire process of developing a drug from preclinical research to marketing can take approximately 12 to 18 years and often costs well over $1 billion. Global Top Pharmaceutical Companies based on projected R&D…

  35. Poster

    Tetrahydro-(2H)-1,3,5-thiadiazine-2-thione (THTT), A versatile carrier system for targeting cell cycle checkpoint pathways with potential anticancer activities

    Tarek Aboul Fadl · Assiut University, Egypt

    Cancer remains a global health threat despite advances in research and technology. According to International Agency for Research on Cancer, the cancer burden will increase by about 77% by 2050, further straining health…

  36. Poster

    Surface chemistry and particle interactions in materials and their impact on powder performance

    Teresa Carvajal · Purdue University, United States

    Surface and physico-chemical properties are critical in formulation and in processes involving the handling, processing, packaging, shelf-life and bioavailability of medicines. In this presentation, we will explore and…

  37. Poster

    From medicationalization to pharmaco pollution: Raising awareness on the hidden Costs of overprescribing

    Andre Luiz Pereira · Escola de Saúde Pública do Estado de Minas Gerais (ESP-MG), Brazil

    The overprescription of pharmaceuticals, a phenomenon known as medicationalization, has led to unintended environmental consequences, contributing to the rising issue of pharmacopollution. This article explores the…

  38. Poster

    Understanding ABC transporters to navigate human diseases

    Ruchika Bajaj · University of California San Francisco, United States

    Membrane proteins constitute 30% of the genome in organisms and are involved in numerous physiological processes. ABC transporters is a class of membrane proteins which are ubiquitously present in all organisms, bind…

Present your research at PDDS 2027

Abstract submissions for the 2027 program are open · September 13–15, 2027 · Olympia Hotel, Events & Spa, Valencia, Spain.

Submit Abstract →

Join the PDDS 2027 delegation

Valencia · September 13–15, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.